- Home
- NBTX vs PHLT Comparison
NBTX vs PHLT Comparison
Compare NBTX & PHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- PHLT
- Stock Information
- Founded
- NBTX 2003
- PHLT 1976
- Country
- NBTX France
- PHLT United States
- Employees
- NBTX N/A
- PHLT N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- PHLT Other Consumer Services
- Sector
- NBTX Health Care
- PHLT Consumer Discretionary
- Exchange
- NBTX Nasdaq
- PHLT Nasdaq
- Market Cap
- NBTX 178.7M
- PHLT 187.1M
- IPO Year
- NBTX 2020
- PHLT N/A
- Fundamental
- Price
- NBTX $3.61
- PHLT $3.00
- Analyst Decision
- NBTX Strong Buy
- PHLT
- Analyst Count
- NBTX 1
- PHLT 0
- Target Price
- NBTX $12.00
- PHLT N/A
- AVG Volume (30 Days)
- NBTX 13.1K
- PHLT 134.8K
- Earning Date
- NBTX 04-23-2025
- PHLT 03-12-2025
- Dividend Yield
- NBTX N/A
- PHLT N/A
- EPS Growth
- NBTX N/A
- PHLT N/A
- EPS
- NBTX N/A
- PHLT N/A
- Revenue
- NBTX $45,220,186.00
- PHLT $122,981,000.00
- Revenue This Year
- NBTX N/A
- PHLT $11.53
- Revenue Next Year
- NBTX N/A
- PHLT N/A
- P/E Ratio
- NBTX N/A
- PHLT N/A
- Revenue Growth
- NBTX 526.17
- PHLT 8.12
- 52 Week Low
- NBTX $2.76
- PHLT $2.26
- 52 Week High
- NBTX $7.51
- PHLT $4.35
- Technical
- Relative Strength Index (RSI)
- NBTX 52.08
- PHLT N/A
- Support Level
- NBTX $3.32
- PHLT N/A
- Resistance Level
- NBTX $3.77
- PHLT N/A
- Average True Range (ATR)
- NBTX 0.21
- PHLT 0.00
- MACD
- NBTX 0.01
- PHLT 0.00
- Stochastic Oscillator
- NBTX 60.55
- PHLT 0.00
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About PHLT Performant Healthcare Inc. Common Stock
Performant Healthcare Inc delivers payment integrity solutions for its healthcare payer clients.